These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30495922)

  • 1. Targeted Graphene Oxide Networks: Cytotoxicity and Synergy with Anticancer Agents.
    Bidram E; Sulistio A; Cho HJ; Amini A; Harris T; Zarrabi A; Qiao G; Stewart A; Dunstan DE
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43523-43532. PubMed ID: 30495922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
    Zhang B; Yang X; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
    Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
    J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of Oridonin and Methotrexate via PEGylated Graphene Oxide.
    Chai D; Hao B; Hu R; Zhang F; Yan J; Sun Y; Huang X; Zhang Q; Jiang H
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):22915-22924. PubMed ID: 31252460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer.
    Miao W; Shim G; Lee S; Lee S; Choe YS; Oh YK
    Biomaterials; 2013 Apr; 34(13):3402-10. PubMed ID: 23380350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells.
    Wu J; Wang YS; Yang XY; Liu YY; Yang JR; Yang R; Zhang N
    Nanotechnology; 2012 Sep; 23(35):355101. PubMed ID: 22875697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
    Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver nanoparticle-embedded graphene oxide-methotrexate for targeted cancer treatment.
    Thapa RK; Kim JH; Jeong JH; Shin BS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 May; 153():95-103. PubMed ID: 28231500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of doxorubicin release from graphene oxide: New approach for optimization of effective parameters on drug loading.
    Hashemi M; Yadegari A; Yazdanpanah G; Omidi M; Jabbehdari S; Haghiralsadat F; Yazdian F; Tayebi L
    Biotechnol Appl Biochem; 2017 May; 64(3):433-442. PubMed ID: 26878983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.
    Elbayoumi TA; Torchilin VP
    Eur J Pharm Sci; 2007 Nov; 32(3):159-68. PubMed ID: 17707615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
    Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells.
    Wu S; Zhao X; Cui Z; Zhao C; Wang Y; Du L; Li Y
    Int J Nanomedicine; 2014; 9():1413-21. PubMed ID: 24672235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGAylated graphene oxide/superparamagnetic nanocomposite as a high-efficiency loading nanocarrier for controlled delivery of methotrexate.
    Abdollahi Z; Taheri-Kafrani A; Bahrani SA; Kajani AA
    J Biotechnol; 2019 Jun; 298():88-97. PubMed ID: 30986517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Sensitive Graphene Oxide Loaded with Proapoptotic Peptides and Anticancer Drugs for Cancer Synergetic Therapy.
    Zhang J; Chen L; Shen B; Chen L; Mo J; Feng J
    Langmuir; 2019 May; 35(18):6120-6128. PubMed ID: 30983368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POxylated graphene oxide nanomaterials for combination chemo-phototherapy of breast cancer cells.
    de Melo-Diogo D; Costa EC; Alves CG; Lima-Sousa R; Ferreira P; Louro RO; Correia IJ
    Eur J Pharm Biopharm; 2018 Oct; 131():162-169. PubMed ID: 30134185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
    Ardeshirzadeh B; Anaraki NA; Irani M; Rad LR; Shamshiri S
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():384-90. PubMed ID: 25579938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.